nodes	percent_of_prediction	percent_of_DWPC	metapath
Zalcitabine—SLC29A1—Fluorouracil—skin cancer	0.248	0.334	CbGbCtD
Zalcitabine—SLC22A7—Fluorouracil—skin cancer	0.0932	0.126	CbGbCtD
Zalcitabine—SLC22A7—Docetaxel—skin cancer	0.0712	0.0959	CbGbCtD
Zalcitabine—CYP2C9—Vismodegib—skin cancer	0.0512	0.069	CbGbCtD
Zalcitabine—CYP3A4—Imiquimod—skin cancer	0.043	0.0579	CbGbCtD
Zalcitabine—CYP3A4—Temozolomide—skin cancer	0.043	0.0579	CbGbCtD
Zalcitabine—CYP2D6—Vemurafenib—skin cancer	0.037	0.0499	CbGbCtD
Zalcitabine—CYP3A4—Vismodegib—skin cancer	0.0298	0.0401	CbGbCtD
Zalcitabine—CYP3A7—Docetaxel—skin cancer	0.0276	0.0372	CbGbCtD
Zalcitabine—CYP3A7-CYP3A51P—Docetaxel—skin cancer	0.0276	0.0372	CbGbCtD
Zalcitabine—CYP3A4—Vemurafenib—skin cancer	0.0235	0.0317	CbGbCtD
Zalcitabine—CYP3A5—Docetaxel—skin cancer	0.0207	0.0279	CbGbCtD
Zalcitabine—CYP2C9—Fluorouracil—skin cancer	0.0182	0.0245	CbGbCtD
Zalcitabine—CYP3A4—Docetaxel—skin cancer	0.00808	0.0109	CbGbCtD
Zalcitabine—Dyspnoea—Imiquimod—skin cancer	0.000286	0.00111	CcSEcCtD
Zalcitabine—Somnolence—Imiquimod—skin cancer	0.000285	0.0011	CcSEcCtD
Zalcitabine—Photosensitivity reaction—Fluorouracil—skin cancer	0.000284	0.0011	CcSEcCtD
Zalcitabine—Alopecia—Bleomycin—skin cancer	0.000283	0.0011	CcSEcCtD
Zalcitabine—Sinusitis—Temozolomide—skin cancer	0.000282	0.00109	CcSEcCtD
Zalcitabine—Dyspepsia—Imiquimod—skin cancer	0.000282	0.00109	CcSEcCtD
Zalcitabine—Decreased appetite—Imiquimod—skin cancer	0.000279	0.00108	CcSEcCtD
Zalcitabine—Hot flush—Docetaxel—skin cancer	0.000278	0.00108	CcSEcCtD
Zalcitabine—Flushing—Dactinomycin—skin cancer	0.000277	0.00107	CcSEcCtD
Zalcitabine—Hypersensitivity—Vemurafenib—skin cancer	0.000277	0.00107	CcSEcCtD
Zalcitabine—Fatigue—Imiquimod—skin cancer	0.000276	0.00107	CcSEcCtD
Zalcitabine—Menopausal symptoms—Docetaxel—skin cancer	0.000275	0.00107	CcSEcCtD
Zalcitabine—Atrial fibrillation—Docetaxel—skin cancer	0.000274	0.00106	CcSEcCtD
Zalcitabine—Pain—Imiquimod—skin cancer	0.000274	0.00106	CcSEcCtD
Zalcitabine—Renal impairment—Docetaxel—skin cancer	0.000273	0.00106	CcSEcCtD
Zalcitabine—Neuropathy peripheral—Fluorouracil—skin cancer	0.000272	0.00105	CcSEcCtD
Zalcitabine—Dermatitis bullous—Docetaxel—skin cancer	0.000272	0.00105	CcSEcCtD
Zalcitabine—Hepatitis—Temozolomide—skin cancer	0.00027	0.00105	CcSEcCtD
Zalcitabine—Asthenia—Vemurafenib—skin cancer	0.00027	0.00104	CcSEcCtD
Zalcitabine—Hallucination—Temozolomide—skin cancer	0.000269	0.00104	CcSEcCtD
Zalcitabine—Pharyngitis—Temozolomide—skin cancer	0.000268	0.00104	CcSEcCtD
Zalcitabine—Chills—Dactinomycin—skin cancer	0.000268	0.00104	CcSEcCtD
Zalcitabine—Cardiac failure—Docetaxel—skin cancer	0.000266	0.00103	CcSEcCtD
Zalcitabine—Pruritus—Vemurafenib—skin cancer	0.000266	0.00103	CcSEcCtD
Zalcitabine—Alopecia—Dactinomycin—skin cancer	0.000264	0.00102	CcSEcCtD
Zalcitabine—Feeling abnormal—Imiquimod—skin cancer	0.000264	0.00102	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Imiquimod—skin cancer	0.000262	0.00101	CcSEcCtD
Zalcitabine—Epistaxis—Fluorouracil—skin cancer	0.000262	0.00101	CcSEcCtD
Zalcitabine—Hyponatraemia—Docetaxel—skin cancer	0.000261	0.00101	CcSEcCtD
Zalcitabine—Visual impairment—Temozolomide—skin cancer	0.00026	0.00101	CcSEcCtD
Zalcitabine—Sinusitis—Fluorouracil—skin cancer	0.00026	0.00101	CcSEcCtD
Zalcitabine—Gastrointestinal haemorrhage—Docetaxel—skin cancer	0.00026	0.00101	CcSEcCtD
Zalcitabine—Pain in extremity—Docetaxel—skin cancer	0.00026	0.00101	CcSEcCtD
Zalcitabine—Ill-defined disorder—Bleomycin—skin cancer	0.000259	0.001	CcSEcCtD
Zalcitabine—Anaemia—Bleomycin—skin cancer	0.000258	0.000998	CcSEcCtD
Zalcitabine—Diarrhoea—Vemurafenib—skin cancer	0.000257	0.000995	CcSEcCtD
Zalcitabine—Migraine—Docetaxel—skin cancer	0.000256	0.00099	CcSEcCtD
Zalcitabine—Urticaria—Imiquimod—skin cancer	0.000255	0.000986	CcSEcCtD
Zalcitabine—Abdominal pain—Imiquimod—skin cancer	0.000253	0.000981	CcSEcCtD
Zalcitabine—Body temperature increased—Imiquimod—skin cancer	0.000253	0.000981	CcSEcCtD
Zalcitabine—Eye disorder—Temozolomide—skin cancer	0.000253	0.000978	CcSEcCtD
Zalcitabine—Tinnitus—Temozolomide—skin cancer	0.000252	0.000976	CcSEcCtD
Zalcitabine—Malaise—Bleomycin—skin cancer	0.000252	0.000974	CcSEcCtD
Zalcitabine—Flushing—Temozolomide—skin cancer	0.000251	0.000971	CcSEcCtD
Zalcitabine—Leukopenia—Bleomycin—skin cancer	0.00025	0.000967	CcSEcCtD
Zalcitabine—Rhinitis—Fluorouracil—skin cancer	0.00025	0.000967	CcSEcCtD
Zalcitabine—Dizziness—Vemurafenib—skin cancer	0.000248	0.000962	CcSEcCtD
Zalcitabine—Pharyngitis—Fluorouracil—skin cancer	0.000247	0.000957	CcSEcCtD
Zalcitabine—Ataxia—Docetaxel—skin cancer	0.000244	0.000946	CcSEcCtD
Zalcitabine—Cough—Bleomycin—skin cancer	0.000243	0.000942	CcSEcCtD
Zalcitabine—Chills—Temozolomide—skin cancer	0.000242	0.000939	CcSEcCtD
Zalcitabine—Ill-defined disorder—Dactinomycin—skin cancer	0.000241	0.000935	CcSEcCtD
Zalcitabine—Anaemia—Dactinomycin—skin cancer	0.00024	0.000931	CcSEcCtD
Zalcitabine—Vomiting—Vemurafenib—skin cancer	0.000239	0.000925	CcSEcCtD
Zalcitabine—Alopecia—Temozolomide—skin cancer	0.000239	0.000925	CcSEcCtD
Zalcitabine—Dry skin—Docetaxel—skin cancer	0.000238	0.000922	CcSEcCtD
Zalcitabine—Myalgia—Bleomycin—skin cancer	0.000237	0.000919	CcSEcCtD
Zalcitabine—Abdominal pain upper—Docetaxel—skin cancer	0.000237	0.000919	CcSEcCtD
Zalcitabine—Rash—Vemurafenib—skin cancer	0.000237	0.000917	CcSEcCtD
Zalcitabine—Dermatitis—Vemurafenib—skin cancer	0.000237	0.000916	CcSEcCtD
Zalcitabine—Hypersensitivity—Imiquimod—skin cancer	0.000236	0.000914	CcSEcCtD
Zalcitabine—Headache—Vemurafenib—skin cancer	0.000235	0.000911	CcSEcCtD
Zalcitabine—Discomfort—Bleomycin—skin cancer	0.000235	0.000908	CcSEcCtD
Zalcitabine—Malaise—Dactinomycin—skin cancer	0.000235	0.000908	CcSEcCtD
Zalcitabine—Cramp muscle—Docetaxel—skin cancer	0.000234	0.000906	CcSEcCtD
Zalcitabine—Leukopenia—Dactinomycin—skin cancer	0.000233	0.000902	CcSEcCtD
Zalcitabine—Nasopharyngitis—Docetaxel—skin cancer	0.000232	0.0009	CcSEcCtD
Zalcitabine—Dysgeusia—Temozolomide—skin cancer	0.00023	0.000892	CcSEcCtD
Zalcitabine—Asthenia—Imiquimod—skin cancer	0.00023	0.00089	CcSEcCtD
Zalcitabine—Confusional state—Bleomycin—skin cancer	0.00023	0.000889	CcSEcCtD
Zalcitabine—Oedema—Bleomycin—skin cancer	0.000228	0.000881	CcSEcCtD
Zalcitabine—Back pain—Temozolomide—skin cancer	0.000228	0.000881	CcSEcCtD
Zalcitabine—Pruritus—Imiquimod—skin cancer	0.000227	0.000878	CcSEcCtD
Zalcitabine—Infection—Bleomycin—skin cancer	0.000226	0.000876	CcSEcCtD
Zalcitabine—Dysphagia—Docetaxel—skin cancer	0.000225	0.000869	CcSEcCtD
Zalcitabine—Thrombocytopenia—Bleomycin—skin cancer	0.000223	0.000863	CcSEcCtD
Zalcitabine—Arrhythmia—Fluorouracil—skin cancer	0.000222	0.000861	CcSEcCtD
Zalcitabine—Vision blurred—Temozolomide—skin cancer	0.000222	0.000859	CcSEcCtD
Zalcitabine—Myalgia—Dactinomycin—skin cancer	0.000221	0.000858	CcSEcCtD
Zalcitabine—Tremor—Temozolomide—skin cancer	0.00022	0.000854	CcSEcCtD
Zalcitabine—Alopecia—Fluorouracil—skin cancer	0.00022	0.000852	CcSEcCtD
Zalcitabine—Diarrhoea—Imiquimod—skin cancer	0.000219	0.000849	CcSEcCtD
Zalcitabine—Discomfort—Dactinomycin—skin cancer	0.000219	0.000847	CcSEcCtD
Zalcitabine—Ill-defined disorder—Temozolomide—skin cancer	0.000218	0.000845	CcSEcCtD
Zalcitabine—Anaemia—Temozolomide—skin cancer	0.000217	0.000842	CcSEcCtD
Zalcitabine—Anorexia—Bleomycin—skin cancer	0.000217	0.00084	CcSEcCtD
Zalcitabine—Agitation—Temozolomide—skin cancer	0.000216	0.000837	CcSEcCtD
Zalcitabine—Oedema—Dactinomycin—skin cancer	0.000212	0.000822	CcSEcCtD
Zalcitabine—Malaise—Temozolomide—skin cancer	0.000212	0.000822	CcSEcCtD
Zalcitabine—Dizziness—Imiquimod—skin cancer	0.000212	0.00082	CcSEcCtD
Zalcitabine—Vertigo—Temozolomide—skin cancer	0.000211	0.000818	CcSEcCtD
Zalcitabine—Infection—Dactinomycin—skin cancer	0.000211	0.000817	CcSEcCtD
Zalcitabine—Leukopenia—Temozolomide—skin cancer	0.000211	0.000815	CcSEcCtD
Zalcitabine—Neutropenia—Docetaxel—skin cancer	0.00021	0.000813	CcSEcCtD
Zalcitabine—Palpitations—Temozolomide—skin cancer	0.000208	0.000805	CcSEcCtD
Zalcitabine—Thrombocytopenia—Dactinomycin—skin cancer	0.000208	0.000805	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000207	0.000803	CcSEcCtD
Zalcitabine—Cough—Temozolomide—skin cancer	0.000205	0.000795	CcSEcCtD
Zalcitabine—Vision blurred—Fluorouracil—skin cancer	0.000204	0.000791	CcSEcCtD
Zalcitabine—Convulsion—Temozolomide—skin cancer	0.000204	0.000789	CcSEcCtD
Zalcitabine—Vomiting—Imiquimod—skin cancer	0.000204	0.000789	CcSEcCtD
Zalcitabine—Weight decreased—Docetaxel—skin cancer	0.000203	0.000787	CcSEcCtD
Zalcitabine—Hypertension—Temozolomide—skin cancer	0.000203	0.000787	CcSEcCtD
Zalcitabine—Dyspnoea—Bleomycin—skin cancer	0.000203	0.000786	CcSEcCtD
Zalcitabine—Anorexia—Dactinomycin—skin cancer	0.000202	0.000784	CcSEcCtD
Zalcitabine—Rash—Imiquimod—skin cancer	0.000202	0.000782	CcSEcCtD
Zalcitabine—Dermatitis—Imiquimod—skin cancer	0.000202	0.000782	CcSEcCtD
Zalcitabine—Headache—Imiquimod—skin cancer	0.000201	0.000777	CcSEcCtD
Zalcitabine—Anaemia—Fluorouracil—skin cancer	0.0002	0.000776	CcSEcCtD
Zalcitabine—Myalgia—Temozolomide—skin cancer	0.0002	0.000776	CcSEcCtD
Zalcitabine—Arthralgia—Temozolomide—skin cancer	0.0002	0.000776	CcSEcCtD
Zalcitabine—Anxiety—Temozolomide—skin cancer	0.0002	0.000773	CcSEcCtD
Zalcitabine—Discomfort—Temozolomide—skin cancer	0.000198	0.000766	CcSEcCtD
Zalcitabine—Decreased appetite—Bleomycin—skin cancer	0.000198	0.000766	CcSEcCtD
Zalcitabine—Neuropathy peripheral—Docetaxel—skin cancer	0.000196	0.00076	CcSEcCtD
Zalcitabine—Dry mouth—Temozolomide—skin cancer	0.000196	0.000759	CcSEcCtD
Zalcitabine—Jaundice—Docetaxel—skin cancer	0.000195	0.000756	CcSEcCtD
Zalcitabine—Pain—Bleomycin—skin cancer	0.000195	0.000754	CcSEcCtD
Zalcitabine—Leukopenia—Fluorouracil—skin cancer	0.000194	0.000751	CcSEcCtD
Zalcitabine—Confusional state—Temozolomide—skin cancer	0.000194	0.00075	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000193	0.000749	CcSEcCtD
Zalcitabine—Oedema—Temozolomide—skin cancer	0.000192	0.000744	CcSEcCtD
Zalcitabine—Infection—Temozolomide—skin cancer	0.000191	0.000739	CcSEcCtD
Zalcitabine—Epistaxis—Docetaxel—skin cancer	0.000189	0.000731	CcSEcCtD
Zalcitabine—Thrombocytopenia—Temozolomide—skin cancer	0.000188	0.000728	CcSEcCtD
Zalcitabine—Convulsion—Fluorouracil—skin cancer	0.000188	0.000727	CcSEcCtD
Zalcitabine—Feeling abnormal—Bleomycin—skin cancer	0.000188	0.000726	CcSEcCtD
Zalcitabine—Skin disorder—Temozolomide—skin cancer	0.000186	0.000722	CcSEcCtD
Zalcitabine—Hyperhidrosis—Temozolomide—skin cancer	0.000186	0.000719	CcSEcCtD
Zalcitabine—Myalgia—Fluorouracil—skin cancer	0.000185	0.000715	CcSEcCtD
Zalcitabine—Decreased appetite—Dactinomycin—skin cancer	0.000185	0.000715	CcSEcCtD
Zalcitabine—Fatigue—Dactinomycin—skin cancer	0.000183	0.000709	CcSEcCtD
Zalcitabine—Anorexia—Temozolomide—skin cancer	0.000183	0.000709	CcSEcCtD
Zalcitabine—Discomfort—Fluorouracil—skin cancer	0.000182	0.000706	CcSEcCtD
Zalcitabine—Pain—Dactinomycin—skin cancer	0.000182	0.000703	CcSEcCtD
Zalcitabine—Urticaria—Bleomycin—skin cancer	0.000181	0.0007	CcSEcCtD
Zalcitabine—Rhinitis—Docetaxel—skin cancer	0.00018	0.000698	CcSEcCtD
Zalcitabine—Body temperature increased—Bleomycin—skin cancer	0.00018	0.000697	CcSEcCtD
Zalcitabine—Hepatitis—Docetaxel—skin cancer	0.00018	0.000696	CcSEcCtD
Zalcitabine—Confusional state—Fluorouracil—skin cancer	0.000178	0.000691	CcSEcCtD
Zalcitabine—Pharyngitis—Docetaxel—skin cancer	0.000178	0.000691	CcSEcCtD
Zalcitabine—Oedema—Fluorouracil—skin cancer	0.000177	0.000685	CcSEcCtD
Zalcitabine—Infection—Fluorouracil—skin cancer	0.000176	0.000681	CcSEcCtD
Zalcitabine—Feeling abnormal—Dactinomycin—skin cancer	0.000175	0.000677	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000175	0.000677	CcSEcCtD
Zalcitabine—Insomnia—Temozolomide—skin cancer	0.000174	0.000672	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Dactinomycin—skin cancer	0.000174	0.000672	CcSEcCtD
Zalcitabine—Thrombocytopenia—Fluorouracil—skin cancer	0.000173	0.000671	CcSEcCtD
Zalcitabine—Visual impairment—Docetaxel—skin cancer	0.000173	0.000671	CcSEcCtD
Zalcitabine—Tachycardia—Fluorouracil—skin cancer	0.000173	0.000669	CcSEcCtD
Zalcitabine—Dyspnoea—Temozolomide—skin cancer	0.000171	0.000663	CcSEcCtD
Zalcitabine—Somnolence—Temozolomide—skin cancer	0.000171	0.000661	CcSEcCtD
Zalcitabine—Dyspepsia—Temozolomide—skin cancer	0.000169	0.000654	CcSEcCtD
Zalcitabine—Anorexia—Fluorouracil—skin cancer	0.000169	0.000653	CcSEcCtD
Zalcitabine—Eye disorder—Docetaxel—skin cancer	0.000168	0.00065	CcSEcCtD
Zalcitabine—Abdominal pain—Dactinomycin—skin cancer	0.000168	0.00065	CcSEcCtD
Zalcitabine—Body temperature increased—Dactinomycin—skin cancer	0.000168	0.00065	CcSEcCtD
Zalcitabine—Hypersensitivity—Bleomycin—skin cancer	0.000168	0.000649	CcSEcCtD
Zalcitabine—Decreased appetite—Temozolomide—skin cancer	0.000167	0.000646	CcSEcCtD
Zalcitabine—Flushing—Docetaxel—skin cancer	0.000167	0.000646	CcSEcCtD
Zalcitabine—Fatigue—Temozolomide—skin cancer	0.000166	0.000641	CcSEcCtD
Zalcitabine—Pain—Temozolomide—skin cancer	0.000164	0.000636	CcSEcCtD
Zalcitabine—Asthenia—Bleomycin—skin cancer	0.000163	0.000632	CcSEcCtD
Zalcitabine—Chills—Docetaxel—skin cancer	0.000161	0.000624	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000161	0.000624	CcSEcCtD
Zalcitabine—Pruritus—Bleomycin—skin cancer	0.000161	0.000624	CcSEcCtD
Zalcitabine—Arrhythmia—Docetaxel—skin cancer	0.000161	0.000622	CcSEcCtD
Zalcitabine—Insomnia—Fluorouracil—skin cancer	0.00016	0.00062	CcSEcCtD
Zalcitabine—Alopecia—Docetaxel—skin cancer	0.000159	0.000615	CcSEcCtD
Zalcitabine—Feeling abnormal—Temozolomide—skin cancer	0.000158	0.000613	CcSEcCtD
Zalcitabine—Dyspnoea—Fluorouracil—skin cancer	0.000158	0.000611	CcSEcCtD
Zalcitabine—Somnolence—Fluorouracil—skin cancer	0.000157	0.000609	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Temozolomide—skin cancer	0.000157	0.000608	CcSEcCtD
Zalcitabine—Hypersensitivity—Dactinomycin—skin cancer	0.000156	0.000606	CcSEcCtD
Zalcitabine—Dyspepsia—Fluorouracil—skin cancer	0.000156	0.000603	CcSEcCtD
Zalcitabine—Decreased appetite—Fluorouracil—skin cancer	0.000154	0.000596	CcSEcCtD
Zalcitabine—Dysgeusia—Docetaxel—skin cancer	0.000153	0.000593	CcSEcCtD
Zalcitabine—Urticaria—Temozolomide—skin cancer	0.000153	0.000591	CcSEcCtD
Zalcitabine—Asthenia—Dactinomycin—skin cancer	0.000152	0.00059	CcSEcCtD
Zalcitabine—Body temperature increased—Temozolomide—skin cancer	0.000152	0.000588	CcSEcCtD
Zalcitabine—Abdominal pain—Temozolomide—skin cancer	0.000152	0.000588	CcSEcCtD
Zalcitabine—Back pain—Docetaxel—skin cancer	0.000151	0.000586	CcSEcCtD
Zalcitabine—Pain—Fluorouracil—skin cancer	0.000151	0.000586	CcSEcCtD
Zalcitabine—Muscle spasms—Docetaxel—skin cancer	0.00015	0.000582	CcSEcCtD
Zalcitabine—Feeling abnormal—Fluorouracil—skin cancer	0.000146	0.000565	CcSEcCtD
Zalcitabine—Diarrhoea—Dactinomycin—skin cancer	0.000145	0.000562	CcSEcCtD
Zalcitabine—Vomiting—Bleomycin—skin cancer	0.000145	0.00056	CcSEcCtD
Zalcitabine—Anaemia—Docetaxel—skin cancer	0.000145	0.00056	CcSEcCtD
Zalcitabine—Rash—Bleomycin—skin cancer	0.000144	0.000556	CcSEcCtD
Zalcitabine—Dermatitis—Bleomycin—skin cancer	0.000143	0.000555	CcSEcCtD
Zalcitabine—Hypersensitivity—Temozolomide—skin cancer	0.000141	0.000548	CcSEcCtD
Zalcitabine—Urticaria—Fluorouracil—skin cancer	0.000141	0.000544	CcSEcCtD
Zalcitabine—Syncope—Docetaxel—skin cancer	0.00014	0.000543	CcSEcCtD
Zalcitabine—Leukopenia—Docetaxel—skin cancer	0.00014	0.000542	CcSEcCtD
Zalcitabine—Body temperature increased—Fluorouracil—skin cancer	0.00014	0.000542	CcSEcCtD
Zalcitabine—Palpitations—Docetaxel—skin cancer	0.000138	0.000535	CcSEcCtD
Zalcitabine—Asthenia—Temozolomide—skin cancer	0.000138	0.000533	CcSEcCtD
Zalcitabine—Loss of consciousness—Docetaxel—skin cancer	0.000138	0.000532	CcSEcCtD
Zalcitabine—Cough—Docetaxel—skin cancer	0.000137	0.000529	CcSEcCtD
Zalcitabine—Pruritus—Temozolomide—skin cancer	0.000136	0.000526	CcSEcCtD
Zalcitabine—Convulsion—Docetaxel—skin cancer	0.000136	0.000525	CcSEcCtD
Zalcitabine—Hypertension—Docetaxel—skin cancer	0.000135	0.000523	CcSEcCtD
Zalcitabine—Vomiting—Dactinomycin—skin cancer	0.000135	0.000523	CcSEcCtD
Zalcitabine—Rash—Dactinomycin—skin cancer	0.000134	0.000518	CcSEcCtD
Zalcitabine—Arthralgia—Docetaxel—skin cancer	0.000133	0.000516	CcSEcCtD
Zalcitabine—Myalgia—Docetaxel—skin cancer	0.000133	0.000516	CcSEcCtD
Zalcitabine—Diarrhoea—Temozolomide—skin cancer	0.000131	0.000509	CcSEcCtD
Zalcitabine—Hypersensitivity—Fluorouracil—skin cancer	0.00013	0.000505	CcSEcCtD
Zalcitabine—Dry mouth—Docetaxel—skin cancer	0.00013	0.000504	CcSEcCtD
Zalcitabine—Confusional state—Docetaxel—skin cancer	0.000129	0.000499	CcSEcCtD
Zalcitabine—Oedema—Docetaxel—skin cancer	0.000128	0.000494	CcSEcCtD
Zalcitabine—Dizziness—Temozolomide—skin cancer	0.000127	0.000492	CcSEcCtD
Zalcitabine—Infection—Docetaxel—skin cancer	0.000127	0.000491	CcSEcCtD
Zalcitabine—Shock—Docetaxel—skin cancer	0.000126	0.000486	CcSEcCtD
Zalcitabine—Pruritus—Fluorouracil—skin cancer	0.000125	0.000485	CcSEcCtD
Zalcitabine—Thrombocytopenia—Docetaxel—skin cancer	0.000125	0.000484	CcSEcCtD
Zalcitabine—Tachycardia—Docetaxel—skin cancer	0.000125	0.000483	CcSEcCtD
Zalcitabine—Skin disorder—Docetaxel—skin cancer	0.000124	0.00048	CcSEcCtD
Zalcitabine—Vomiting—Temozolomide—skin cancer	0.000122	0.000473	CcSEcCtD
Zalcitabine—Anorexia—Docetaxel—skin cancer	0.000122	0.000471	CcSEcCtD
Zalcitabine—Rash—Temozolomide—skin cancer	0.000121	0.000469	CcSEcCtD
Zalcitabine—Diarrhoea—Fluorouracil—skin cancer	0.000121	0.000469	CcSEcCtD
Zalcitabine—Dermatitis—Temozolomide—skin cancer	0.000121	0.000468	CcSEcCtD
Zalcitabine—Headache—Temozolomide—skin cancer	0.00012	0.000466	CcSEcCtD
Zalcitabine—Dizziness—Fluorouracil—skin cancer	0.000117	0.000453	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000116	0.00045	CcSEcCtD
Zalcitabine—Insomnia—Docetaxel—skin cancer	0.000115	0.000447	CcSEcCtD
Zalcitabine—Dyspnoea—Docetaxel—skin cancer	0.000114	0.000441	CcSEcCtD
Zalcitabine—Somnolence—Docetaxel—skin cancer	0.000114	0.00044	CcSEcCtD
Zalcitabine—Vomiting—Fluorouracil—skin cancer	0.000112	0.000436	CcSEcCtD
Zalcitabine—Dyspepsia—Docetaxel—skin cancer	0.000112	0.000435	CcSEcCtD
Zalcitabine—Rash—Fluorouracil—skin cancer	0.000112	0.000432	CcSEcCtD
Zalcitabine—Dermatitis—Fluorouracil—skin cancer	0.000111	0.000432	CcSEcCtD
Zalcitabine—Decreased appetite—Docetaxel—skin cancer	0.000111	0.00043	CcSEcCtD
Zalcitabine—Headache—Fluorouracil—skin cancer	0.000111	0.000429	CcSEcCtD
Zalcitabine—Fatigue—Docetaxel—skin cancer	0.00011	0.000426	CcSEcCtD
Zalcitabine—Pain—Docetaxel—skin cancer	0.000109	0.000423	CcSEcCtD
Zalcitabine—Feeling abnormal—Docetaxel—skin cancer	0.000105	0.000407	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Docetaxel—skin cancer	0.000104	0.000404	CcSEcCtD
Zalcitabine—Abdominal pain—Docetaxel—skin cancer	0.000101	0.000391	CcSEcCtD
Zalcitabine—Body temperature increased—Docetaxel—skin cancer	0.000101	0.000391	CcSEcCtD
Zalcitabine—Hypersensitivity—Docetaxel—skin cancer	9.41e-05	0.000364	CcSEcCtD
Zalcitabine—Asthenia—Docetaxel—skin cancer	9.16e-05	0.000355	CcSEcCtD
Zalcitabine—Pruritus—Docetaxel—skin cancer	9.03e-05	0.00035	CcSEcCtD
Zalcitabine—Diarrhoea—Docetaxel—skin cancer	8.74e-05	0.000338	CcSEcCtD
Zalcitabine—Dizziness—Docetaxel—skin cancer	8.44e-05	0.000327	CcSEcCtD
Zalcitabine—Vomiting—Docetaxel—skin cancer	8.12e-05	0.000314	CcSEcCtD
Zalcitabine—Rash—Docetaxel—skin cancer	8.05e-05	0.000312	CcSEcCtD
Zalcitabine—Dermatitis—Docetaxel—skin cancer	8.04e-05	0.000311	CcSEcCtD
Zalcitabine—Headache—Docetaxel—skin cancer	8e-05	0.00031	CcSEcCtD
